Blood Donation Screening and West Nile Virus Surveillance Strategy in France | Synapse
September 10, 2025Open Access
Blood Donation Screening and West Nile Virus Surveillance Strategy in France
Key Points
Nucleic acid testing improves blood donation safety by screening for west nile virus in France, enhancing public health measures.
The case series shows effective utilization of nucleic acid testing for detecting the virus in blood donations across impacted areas.
A comprehensive screening approach, using nucleic acid testing, enables better surveillance of west nile virus transmission risk.
Matching previous virus circulation data with current testing helps optimize strategies for monitoring and responding to potential outbreaks.
Abstract
This case series describes the use of nucleic acid testing in screening blood donations for West Nile virus in areas of France in which the virus circulated in previous years.